acquired
Stage
About
NeoMend was a biomedical startup acquired by C.R. Bard, Inc., specializing in medical or biomedical technologies.
Explore NeoMend's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.